Stephanie Drew
Family · Milwaukee, WINPI 1235408691
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,046 of the $4,699 with a category attached, or 86.1%. 19 manufacturers reported payments, led by Boston Scientific at 30.3% of the total. Reporting peaked in 2024 at $1,373 and has fallen 86.0% since, to $193 in 2025. Among family clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $39.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$705
- Abbott$678
- Nevro Corp.$390
- SPR Therapeutics, Inc$271
- IBSA Pharma Inc.$262
- plus $968 from 13 others
Across 1 payment — averaging $140.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$140
What the payments were for
- Travel & lodging$65314%
- Food & beverage$4,04686%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $1,425 |
| Medtronic | 22 | $705 |
| Abbott | 9 | $678 |
| Nevro Corp. | 4 | $390 |
| SPR Therapeutics, Inc | 4 | $271 |
| IBSA Pharma Inc. | 16 | $262 |
| Collegium Pharmaceutical, Inc. | 15 | $207 |
| Pfizer | 10 | $194 |
| AbbVie | 6 | $126 |
| BTG International Inc. | 1 | $82 |
| Lilly USA, LLC | 5 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Scilex Pharmaceuticals Inc. | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $45 |
| Sanofi | 1 | $30 |
| Optinose US, Inc. | 1 | $27 |
| Almatica Pharma LLC | 1 | $18 |
| Amgen | 1 | $16 |
| Relievant Medsystems, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$779
- ETERNA$445
- Vanta$175
- WaveWriter Alpha Prime 16$166
- SPRINT PNS System$150
- Senza$148
- Omnia$139
- GENERAL PAIN MANAGEMENT$139
- INTELLIS ADAPTIVESTIM$132
How this compares
$4,699 in reported general payments places this provider in the 95th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 17 | $27,048 |
| Nurtec OdtRimegepant Sulfate | 16 | $26,037 |
| NucyntaTapentadol Hcl | 25 | $21,450 |
| BelbucaBuprenorphine Hcl | 25 | $20,528 |
| Nucynta ErTapentadol Hcl | 15 | $13,565 |
| Xtampza ErOxycodone Myristate | 22 | $9,587 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 244 | $6,719 |
| Buprenorphine | 28 | $6,066 |
| OxycontinOxycodone Hcl | 11 | $2,893 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 105 | $2,630 |
| Gabapentin | 131 | $2,388 |
| Morphine Sulfate ErMorphine Sulfate | 36 | $1,406 |
| Tizanidine Hcl | 96 | $1,185 |
| Diclofenac Sodium | 23 | $1,055 |
| Oxycodone Hcl | 54 | $940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca, Nucynta Er, Xtampza Er | $207 | $65,13087 claims |
| AbbVieUbrelvy | $126 | $27,04817 claims |
| PfizerNurtec Odt | $194 | $26,03716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,273 family providers in Wisconsin.
Other family in Milwaukee
- Stephanie OffordMilwaukee$116K
- Tracy NelsonMilwaukee$24K
- Sarah EmmerichMilwaukee$15K
- Erin LassanskeMilwaukee$14K
- Katrina BaxterMilwaukee$13K
- Natalie KerberMilwaukee$12K
- Jenta AlexanderMilwaukee$12K
- Lileta WintMilwaukee$10K
- Mary Jane de JesusMilwaukee$10K
- Kelley BeltranMilwaukee$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.